Company logo

ADXS - Advaxis, Inc.

NASDAQ -> Healthcare -> Biotechnology
Monmouth Junction, United States
Type: Equity

ADXS price evolution
ADXS
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 30 Sep 2022
Current assets
Cash $2.12 $7.08 $16.84 $25.21
Short term investments $0.1 $0.11 $0.11
Net receivables $0
Inventory
Total current assets $4.55 $9.56 $18.26 $25.76
Long term investments
Property, plant & equipment $2.12 $2.27 $2.39 $0.05
Goodwill & intangible assets $0.11 $0.12 $0.13 $0.11
Total noncurrent assets $2.43 $2.6 $2.73 $0.17
Total investments $0.1 $0.11 $0.11
Total assets $6.98 $12.15 $21 $25.93
Current liabilities
Accounts payable $5.26 $4.58 $5.83 $0.02
Deferred revenue
Short long term debt $0.48 $0.54 $0.25 $0.01
Total current liabilities $8.53 $8.43 $9.83 $2.3
Long term debt $3 $1 $1.41
Total noncurrent liabilities $4.7 $2.71 $1.49
Total debt $3.48 $1.54 $1.66 $0.01
Total liabilities $13.22 $11.14 $11.32 $2.3
Shareholders' equity
Retained earnings -$172.55 -$165.21 -$156.51 -$442.96
Other shareholder equity
Total shareholder equity -$6.24 $1.01 $9.68 $23.63
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Current assets
Cash $25.21 $41.61 $25.18 $32.36
Short term investments
Net receivables
Inventory
Total current assets $25.76 $43.26 $27.85 $36.15
Long term investments
Property, plant & equipment $0.05 $0.16 $7.23 $4.35
Goodwill & intangible assets $0.11 $3.35 $3.26 $4.58
Total noncurrent assets $0.17 $3.52 $10.68 $9.11
Total investments
Total assets $25.93 $46.78 $38.53 $45.26
Current liabilities
Accounts payable $0.02 $0.09 $0.41 $0.98
Deferred revenue $0.17
Short long term debt $0.01 $0.03 $0.96
Total current liabilities $2.3 $7.88 $3.29 $4.52
Long term debt $0.01 $5.05
Total noncurrent liabilities $0.01 $5.05 $1.21
Total debt $0.01 $0.04 $6.02
Total liabilities $2.3 $7.89 $8.35 $5.73
Shareholders' equity
Retained earnings -$442.96 -$428.6 -$410.74 -$384.27
Other shareholder equity
Total shareholder equity $23.63 $38.89 $30.18 $39.53
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 30 Sep 2022
Revenue
Total revenue $0.01 $0
Cost of revenue $0.01 $0
Gross Profit
Operating activities
Research & development $5.68 $5.72 $7.26 $2.25
Selling, general & administrative $1.45 $2.76 $4.6 $2.56
Total operating expenses $7.13 $8.49 $11.87 $4.85
Operating income -$7.13 -$8.49 -$11.87 -$4.85
Income from continuing operations
EBIT -$7.27 -$8.57 -$11.57 -$4.59
Income tax expense $0.07 $0.13 -$4.21
Interest expense
Net income
Net income -$7.34 -$8.7 -$7.36 -$4.59
Income (for common shares) -$7.34 -$8.7 -$7.36 -$4.59
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Revenue
Total revenue $0.25 $3.24 $0.25 $20.88
Cost of revenue
Gross Profit $0.25 $3.24 $0.25 $20.88
Operating activities
Research & development $7.62 $10.56 $15.61 $26.68
Selling, general & administrative $8.89 $11.46 $11.09 $12.18
Total operating expenses $19.56 $22.03 $26.7 $38.86
Operating income -$19.31 -$18.79 -$26.45 -$17.97
Income from continuing operations
EBIT -$14.31 -$17.81 -$26.42 -$16.56
Income tax expense $0.05 $0.05 $0.05 $0.05
Interest expense
Net income
Net income -$14.36 -$17.86 -$26.47 -$16.61
Income (for common shares) -$15.38 -$17.86 -$26.47 -$16.61
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 30 Sep 2022
Net income -$7.34 -$8.7 -$7.36 -$4.59
Operating activities
Depreciation $0.04 $0.06 $0.04 $0.01
Business acquisitions & disposals
Stock-based compensation $0.09 $0.03 $1.19 $0.02
Total cash flows from operations -$6.98 -$8.56 -$6.74 -$2.98
Investing activities
Capital expenditures $0.04
Investments
Total cash flows from investing $0.04
Financing activities
Dividends paid
Sale and purchase of stock -$1.2
Net borrowings $2
Total cash flows from financing $2 -$1.2 $21.2
Effect of exchange rate $0.01 -$0.01 -$0.04
Change in cash and equivalents -$4.97 -$9.77 $14.42 -$2.94
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Net income -$14.36 -$17.86 -$26.47 -$16.61
Operating activities
Depreciation $0.08 $0.72 $1.64 $1.1
Business acquisitions & disposals
Stock-based compensation $0.1 $0.57 $0.89 $2
Total cash flows from operations -$15.28 -$15.44 -$21.94 -$36.13
Investing activities
Capital expenditures $0.04 $0.45 $0.03
Investments
Total cash flows from investing -$0.17 -$0.01 -$0.75 -$1.2
Financing activities
Dividends paid
Sale and purchase of stock -$0.02 $31.89 $15.5 $24.49
Net borrowings
Total cash flows from financing -$0.96 $31.89 $15.5 $24.57
Effect of exchange rate
Change in cash and equivalents -$16.41 $16.44 -$7.18 -$12.76
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding N/A
Revenue $13.00K
EBITDA -$31.85M
EBIT -$32.01M
Net Income -$27.99M
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA -169.49%
ROE -398.86%
Debt/Equity 0.10
Net debt/EBITDA -0.35
Current ratio 0.53
Quick ratio 0.53